Position in TSHA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$44,676,282
+$19,948,444 QoQ
Shares Held
6,560,394
+18.6% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 208 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. TSHA ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in TSHA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,676,282 | 6,560,394 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $24,727,838 | 5,531,955 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,628,643 | 5,387,026 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $16,920,667 | 5,174,516 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $8,763,151 | 3,793,572 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,093,977 | 3,664,732 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,180,163 | 3,572,349 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,161,142 | 3,562,758 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,452,285 | 2,880,485 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,926,800 | 1,019,791 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,744,195 | 985,421 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,458,864 | 461,666 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $236,540 | 357,853 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $300,418 | 376,464 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $749,734 | 331,741 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $464,000 | 240,415 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $886,249 | 238,239 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,670,396 | 409,570 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,553,414 | 390,851 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,759,357 | 363,016 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,584,970 | 263,442 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,094,978 | 152,462 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,347,623 | 163,814 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||